US-FDA + 7 More
Ophthalmics +2 More
US-FDA + 17 More
I - 1999 & II - 2002
UK-MHRA + 11 more
Tablets + 1 more
UK-MHRA + 12 More
ORS plant - 1998 & Food Plant - 2014
ORS + Functional Foods
WHO-GMP + 7 More
US-FDA + 1 more
To achieve consistent results, batch after batch, a central quality team has defined exhaustive SOPs which are constantly improved and optimized. This framework is built by leading experts from our Quality Control, Quality Assurance, Research and Development and Manufacturing departments.
At our plants, our focus is on constant monitoring, logging and optimizations. The circular process of Monitor, Assess, Realign and Repeat builds an iterative and constantly improving mechanism. Batch validation is done under stringent parameters to ensure large-scale reproducibility and regular team huddles bring a sense of cohesion across different departments.
By leveraging technology, we have reduced human intervention to wherever possible and have automated our processes that is decentralized, protected and logged.
Our overarching objective of making healthcare affordable is made possible by improving processes at our facilities. Avoiding wastage of product, service design activities, process innovation and agile responses have helped us reduce cost of manufacturing.